CJC-1295 NO DAC (Mod GRF 1-29) (5mg)
Special Price
$1,571.21
was
$2,058.40
-
-
Research Benefits:
Growth Hormone Regulation: CJC-1295 NO DAC (Mod GRF 1-29) is frequently used in research settings for its ability to stimulate natural, pulsatile GH release through GHRH receptor activation.
Peptide Kinetics Studies: Valuable in short-duration studies due to its shorter half-life compared to DAC variants, allowing for more precise control in experimental timelines.
Neuroendocrine Modeling: Utilized to explore the feedback mechanisms of the hypothalamic-pituitary axis and GH secretion cycles in controlled laboratory systems.
Bioavailability Research: Commonly employed in pharmacokinetic studies due to its rapid onset and minimized systemic saturation over extended timeframes.
High-Purity Formulation: CJC-1295 NO DAC is synthesized to >99% purity for accurate, repeatable results in peptide-focused in vitro and preclinical research applications.
Money Back
Gaurantee
Satisfaction
Guarantee
Same Day
Shipping
99%
Purity
Premium
Quality
Third Party
Tested
CJC-1295 NO DAC (Mod GRF 1-29) (5mg)
GHRH Analog for Growth Hormone Pulse and Endocrine Research
CJC-1295 NO DAC (Mod GRF 1-29) (5mg) is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), specifically engineered for short-duration studies of growth hormone (GH) pulsatility and endocrine signaling. Also known as Modified GRF 1-29, this peptide omits the drug affinity complex (DAC) to preserve natural, physiologic GH release patterns in research settings.
Product Overview
This 5mg vial of lyophilized CJC-1295 NO DAC is manufactured at >99% purity and is widely used in in vitro models analyzing hypothalamic-pituitary activity, GH feedback loops, and pituitary responsiveness. Its shorter half-life offers researchers precise control over hormone study timing and receptor activation periods.
Key Research Attributes:
- Short-Acting GHRH Analog: Modified for stability without DAC, enabling study of natural GH pulses without extended stimulation.
- GH Secretion and Pituitary Study: Used in controlled experiments to analyze pulsatile GH release and downstream signaling.
- Endocrine Regulation Models: Supports investigation of hypothalamic-pituitary-adrenal (HPA) axis function and receptor activation feedback.
- Research-Grade Purity: Lyophilized for stability and consistent performance in endocrine research applications.
Applications in Scientific Research
- Growth hormone pulsatility and feedback loop studies
- GH-releasing hormone receptor activity experiments
- Endocrine axis modulation models
- Comparative analysis with CJC-1295 DAC and other GHRH analogs
- In vitro pituitary cell activation and hormone release studies
Format and Storage
Form: Lyophilized powder
Purity: >99%
Storage: Store at -20°C in a sealed container
Reconstitution: Reconstitute with sterile bacteriostatic water in lab conditions
Disclaimer: CJC-1295 NO DAC (Mod GRF 1-29) (5mg) is provided for in vitro scientific research use only. It is not for human or veterinary use. Research must adhere to institutional and legal requirements.
Chemical Makeup
Molecular Formula
- CJC-1295 NO DAC: C152H252N44O42
Molecular Weight
- CJC-1295 NO DAC: 3367.9 g/mol
Sequence
- CJC-1295 NO DAC: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
Other Known Titles
- CJC-1295 NO DAC: Modified GRF 1-29, CJC-1295 w/o DAC, Mod GRF (1-29)
CJC-1295 NO DAC (Mod GRF 1-29) (5mg) is intended strictly for laboratory and research use. Please review our Terms and Conditions before purchase.
| Research | CJC-1295 without DAC: Effects, Benefits, and Side EffectsCJC-1295 without Drug Affinity Complex (DAC), also known as Modified GRF (1-29), is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to stimulate the secretion of growth hormone (GH). Unlike its counterpart with DAC, this form has a shorter half-life, leading to a more pulsatile release of GH. Below are ten reputable sources that provide insights into CJC-1295 without DAC, including its effects, benefits, and potential side effects:
|
|---|
CJC-1295 without DAC: Effects, Benefits, and Side Effects
CJC-1295 without Drug Affinity Complex (DAC), also known as Modified GRF (1-29), is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to stimulate the secretion of growth hormone (GH). Unlike its counterpart with DAC, this form has a shorter half-life, leading to a more pulsatile release of GH. Below are ten reputable sources that provide insights into CJC-1295 without DAC, including its effects, benefits, and potential side effects:
-
“CJC 1295 Peptide Guide – Benefits, Effects, Dosage, Side Effects”
This comprehensive guide discusses the benefits of CJC-1295, including increased lean muscle mass and fat loss, and explores its combination with peptides like GHRP-2 for enhanced effects. Read more -
“CJC-1295 Side Effects, Complications, and Risk Profile”
This article examines the potential side effects of CJC-1295, such as injection site reactions and water retention, and discusses safety considerations when used alone or in combination with other peptides. Read more -
“CJC-1295 With and Without DAC: Complete Guide”
This source provides a comparative analysis of CJC-1295 with and without DAC, detailing their mechanisms of action, benefits, and considerations for combined use. Read more -
“CJC-1295 | Reviews, Clinical Trials, and Safety”
This comprehensive review covers clinical trials and safety profiles of CJC-1295, including its effects on growth hormone levels and potential benefits when combined with other peptides. Read more -
“Guide to CJC-1295: Efficiency and Proper Use”
This article delves into the efficiency and proper use of CJC-1295, discussing its benefits, dosage recommendations, and potential side effects. Read more -
“CJC 1295 DAC vs. No DAC: Understanding the Differences”
This piece explores the differences between CJC-1295 with and without DAC, their synergistic effects, dosage recommendations, and potential side effects. Read more -
“CJC 1295: Benefits, Dosage, Side Effects, & Scientific Research”
This source provides an overview of CJC-1295, detailing its mechanisms, benefits like increased appetite and muscle growth, and potential side effects, including elevated cortisol levels. Read more -
“CJC 1295 Side Effects: What You Need to Know”
This article delves into the side effects associated with CJC-1295, such as dizziness and increased body temperature, and discusses considerations when combining it with peptides like GHRP-2. Read more -
“CJC-1295 DAC vs. CJC-1295 No DAC | What’s the Difference?”
This article compares CJC-1295 with and without DAC, discussing their individual benefits, side effects, and the potential advantages of using them in combination for therapeutic purposes. Read more -
“CJC-1295 Benefits and Research Applications”
This comprehensive guide covers the benefits, side effects, and dosage recommendations for CJC-1295, including its combined use with other peptides. Read more
Log In